Compare ACRS & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRS | GTN |
|---|---|---|
| Founded | 2012 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.9M | 432.5M |
| IPO Year | 2015 | 1996 |
| Metric | ACRS | GTN |
|---|---|---|
| Price | $3.77 | $4.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $10.18 | $6.50 |
| AVG Volume (30 Days) | ★ 3.5M | 829.9K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 6.81% |
| EPS Growth | ★ 69.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,683,000.00 | ★ $3,095,000,000.00 |
| Revenue This Year | N/A | $17.38 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.10 | $3.55 |
| 52 Week High | $6.60 | $6.44 |
| Indicator | ACRS | GTN |
|---|---|---|
| Relative Strength Index (RSI) | 39.97 | 50.33 |
| Support Level | $3.18 | $4.47 |
| Resistance Level | $3.86 | $4.70 |
| Average True Range (ATR) | 0.31 | 0.18 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 54.05 | 52.63 |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.